TAF vs. TDF: Measuring Lipid Levels in HIV Treatment
November 22nd 2019TAF causes cholesterol levels to rise, but that includes levels of “good cholesterol” HDL. Researchers concluded that there is no significant difference in cardiovascular risk profiles between people taking TAF and those taking TDF.
Management Bundle Lowers Mortality in Enterococcal Bloodstream Infections
November 15th 2019The introduction of a bundle of interventions, including infectious disease consultation, echocardiography, follow-up blood cultures and targeted antimicrobial treatment was linked to lower mortality in enterococcal bloodstream infection, a new study found.
Cefiderocol Approved by FDA for cUTI
November 15th 2019Cefiderocol has been approved for the treatment of complicated urinary tract infections (cUTI), including kidney infections caused by susceptible gram-negative microorganisms, who have limited or no alternative treatment options. Labeling includes a warning regarding the higher all-cause mortality rate in the CREDIBLE-CR study.